Potential Use of Iron Chelators against Oxidative Damage
- 1 January 1996
- book chapter
- Published by Elsevier
- Vol. 38, 167-203
- https://doi.org/10.1016/s1054-3589(08)60984-9
Abstract
No abstract availableThis publication has 126 references indexed in Scilit:
- Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminium chelating drugsToxicology Letters, 1995
- Structure/Activity Relationships Affecting the Ability of Monoanionic 3-Hydroxypyrid-4-ones to Mobilize IronChemical Research in Toxicology, 1994
- New roles for quin2: Powerful transition-metal ion chelator that inhibits copper-, but potentiates iron-driven, fenton-type reactionsFree Radical Biology & Medicine, 1994
- Pharmacodynamics of the Hydrolysis-Activation of the Cardioprotective Agent (+)-1,2-Bis(3,5-dioxopiperazinyl-1-yl)propaneJournal of Pharmaceutical Sciences, 1994
- Iron-mediated DNA damage: Sensitive detection of DNA strand breakage catalyzed by ironJournal of Inorganic Biochemistry, 1992
- Prooxidant action of desferrioxamine: Fenton-like production of hydroxyl radicals by reduced ferrioxamineJournal of Free Radicals in Biology & Medicine, 1986
- Brain iron delocalization and lipid peroxidation following cardiac arrestAnnals of Emergency Medicine, 1986
- Failure of desferrioxamine to modify the toxicity of paraquat in ratsJournal of Free Radicals in Biology & Medicine, 1985
- On the cytotoxicity of vitamin C and metal ionsEuropean Journal of Biochemistry, 1983
- Mobilization of iron from reticulocytesFEBS Letters, 1979